The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2014

Filed:

Sep. 20, 2012
Applicant:

Council of Scientific and Industrial Research, New Delhi, IN;

Inventors:

Arvind Singh Negi, Lucknow, IN;

Ayyampudur Palanisamy Prakasham, Lucknow, IN;

Ajit Kumar Saxena, Jammu, IN;

Suaib Luqman, Lucknow, IN;

Debabrata Chanda, Lucknow, IN;

Tandeep Kaur, Jammu, IN;

Atul Gupta, Lucknow, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/36 (2006.01); A61K 31/12 (2006.01); C07D 317/54 (2006.01); C07C 49/755 (2006.01); C07C 201/12 (2006.01); C07C 45/72 (2006.01); C07C 205/45 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to benzylidene indanones of general formula 1. The compounds exhibited tubulin polymerisation inhibition. A series of compounds 2-benzylidene 3-(3,4,5-trimethoxyphenyl) indanones having general formula 1 were synthesized from gallic acid through a chemical process. 2-(3,4-Methylenedioxybenzylidine), 3-(3,4,5-trimethoxyphenyl), 4,5,6-trimethoxyindanone (8), a representative compound of this series possessing the molecular formula CHO, was synthesized from gallic acid and exhibits potent anticancer activity. Compound 8 was evaluated for acute oral activity in Swiss albino mice and found to be safe up to 300 mg/kg body weight. The anticancer activity of the compounds has been determined, in order to obtain new potent and cost effective molecules using an in vitro cytotoxicity assay.


Find Patent Forward Citations

Loading…